Smith B J BJ - OmicsDI

Show results for

Unknown (842)
Proteomics (24)
Genomics (20)
Metabolomics (8)
Transcriptomics (7)
Multiomics (1)

Organisms

Homo sapiens (35)
Mus musculus (5)
Yarrowia lipolytica (2)
Cucurbita maxima (1)
Saccharomyces cerevisiae (1)

Repository

EGA (20)
pride (17)
MetaboLights (8)
biostudies-arrayexpress (7)
MassIVE (7)

Tissue

Cell culture (5)
Epithelial cell (5)
B cell (2)
B-cell chronic lymphocytic leukemia cell (2)
Monocyte (2)
Adipocyte (1)
Brain (1)
Breast cancer cell (1)
Embryo (1)
Fibroblast (1)
Liver (1)
Lung (1)
Medulloblastoma cell (1)
Mesenteric adipose tissue (1)
Nectar (1)
Nectary (1)
Neuronal stem cell (1)
Primary cell (1)
Spleen (1)
Stem cell (1)
Subcutaneous adipose tissue (1)

Disease

Avian influenza (3)
Influenza (3)
COVID-19 (2)
Chronic lymphocytic leukemia (2)
Acute leukemia (1)
Amyotrophic lateral sclerosis (1)
Breast cancer (1)
Disease free (1)
Lysosomal storage disease (1)
Niemann-Pick disease type C2 (1)

Technology Type

Mass Spectrometry (17)
Mass spectrometry (8)
Shotgun proteomics (8)
Bottom-up proteomics (3)
Data-dependent acquisition (3)
Affinity purification coupled with mass spectrometry proteomics (2)
SWATH MS (2)
Data-independent acquisition (1)
HDMSE (1)
SRM/MRM (1)

Instrument Platform

LTQ Orbitrap Velos (3)
RiboZero (2)
Trizol (Invitrogen); FastPrep (MP Biochemicals) (2)
DASGIP bioreactors (2)
Ion Torrent Proton (2)
Q Exactive (2)
5975C Series GC/MSD (Agilent) (2)
Liquid Chromatography MS - positive - reverse phase (2)
LCQ Classic (1)
Orbitrap Astral (1)
6520 Q-TOF LC/MS (Agilent) (1)
LTQ Orbitrap Velos (Thermo Scientific) (1)
Liquid Chromatography MS - Negative (LC-MS (Negative)) (1)
Liquid Chromatography MS - Positive (LC-MS (Positive)) (1)
Liquid Chromatography MS - alternating - hilic (1)
Liquid Chromatography MS - negative - reverse phase (1)
MS Imaging - (1)

Publication Date

2016 (7)
2022 (5)
2023 (4)
2021 (3)
2020 (3)
2025 (3)
2017 (2)
2015 (2)
2018 (2)
2024 (2)
2012 (1)
2011 (1)
2008 (1)
2013 (1)
2019 (1)

CHEBI ID

CHEBI:15971 (3)
CHEBI:16015 (3)
CHEBI:17368 (3)
CHEBI:15318 (2)
CHEBI:15354 (2)
CHEBI:15428 (2)
CHEBI:15430 (2)
CHEBI:15603 (2)
CHEBI:15729 (2)
CHEBI:15756 (2)
CHEBI:16092 (2)
CHEBI:16196 (2)
CHEBI:16414 (2)
CHEBI:16467 (2)
CHEBI:16610 (2)
CHEBI:16643 (2)
CHEBI:16737 (2)
CHEBI:16857 (2)
CHEBI:16919 (2)
CHEBI:16988 (2)
CHEBI:17053 (2)
CHEBI:17115 (2)
CHEBI:17191 (2)
CHEBI:17203 (2)
CHEBI:17561 (2)
CHEBI:17724 (2)
CHEBI:17821 (2)
CHEBI:17895 (2)
CHEBI:17929 (2)
CHEBI:18019 (2)

Metabolite Name

Xanthine (3)
11-Dehydrocorticosterone (2)
4-Hydroxybenzaldehyde (2)
Allantoin (2)
Choline (2)
Creatine (2)
Creatinine (2)
Dimethylglycine (2)
Glycine (2)
Hypoxanthine (2)
Isoquinoline (2)
L-Arginine (2)
L-Glutamate (2)
L-Histidine (2)
Methylimidazoleacetic acid (2)
Omega-Cyclohexylundecanoic acid (2)
Pyruvate (2)
Sebacic acid (2)
Suberic acid (2)
Thymine (2)
Uridine (2)
()-Octanoylcarnitine (1)
(+)-15-nor-4-thujopsen-3-one (1)
(-)-11-Hydroxy-9,15,16-trioxooctadecanoic acid (1)
(-)-Epigallocatechin (1)
(.+/-.)-Lyoniresinol 2a-O-.beta.-D-glucopyranoside (1)
(.alpha.S,1S,2R)-.alpha.-Amino-2-carboxycyclopropaneacetic acid (1)
(1-Acetyloxy-3-hydroxy-6,8a-dimethyl-7-oxo-3-propan-2-yl-2,3a,4,8-tetrahydro-1H-azulen-4-yl) 4-hydroxybenzoate (1)
(1-Hydroxycyclohexyl)acetic acid (1)
(10S)-Juvenile hormone III diol (1)

Study type

RNA-seq of coding RNA (3)
Transcription profiling by array (2)
Transcription profiling by SAGE (1)
Comparative genomic hybridization by array (1)

Release Date

2021 (97)
2022 (85)
2020 (82)
2024 (72)
2023 (69)
2025 (65)
2015 (48)
2019 (44)
2014 (42)
2013 (41)
2016 (34)
2012 (32)
2018 (31)
2017 (29)
2011 (29)
2026 (15)
2010 (14)
2009 (10)
2008 (6)
2007 (3)
2006 (1)

Lab affiliation

1Lester and Sue Smith Breast Center and Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA (1)
Associate professor at University of Campinas-SP (UNICAMP-SP) (1)
Department of Biochemistry Biophysics and Molecular Biology, Iowa State University, Ames, IA, USA (1)
Department of Biochemistry and Center for Cancer Research, Purdue University, West Lafayette, Indiana 47907 (1)
Department of Biochemistry and Chemistry, LIMS, La Trobe University, Kingsbury Drive, Bundoora, Vic 3086, Australia (1)
Department of Biochemistry and Tissue Biology, Institute of Biology, University of Campinas, Campinas, SP, Brazil (1)
Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY 14642, USA Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY 14642, USA (1)
Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA. (1)
Department of Neurology, University of Massachusetts Medical School, Worcester, MA, 01605, USA. (1)
Department of Oncology-Pathology, Karolinska Institutet and Science for Life Laboratory (1)
Dept. Cellular Molecular Pharmacology, University of California - San Francisco (UCSF), USA (1)
Dept. Cellular Molecular Pharmacology, University of San Francisco (UCSF), USA (1)
Dept. Cellular and Molecular Pharmacology, University of California - San Francisco (UCSF), USA (1)
Duke University Dept of Biochemistry (1)
Head of the Curie Institute Mass Spectrometry Platform (1)
Pacific Northwest National Laboratory (1)
Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden (1)

Previous page
1 / 91
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 91
Next page

Sort by:

Relevance

Page size

Proteogenomic subtyping of chronic lymphocytic leukemia identifies subgroups with contrasting clinical outcome and distinct ex-vivo drug response profile

We have performed a comprehensive proteomic analysis of clinical patient samples of chronic lymphocytic leukemia (CLL) alongside genome-, transcriptome- and ex-vivo drug response profiling. Trisomy 12 and IGHV mutation status had the strongest impact on the proteome and transcriptome; and SF3B1 muta...

ORGANISM(S): Homo sapiens (Human)

2024-06-21 | PXD017453 | Pride

Proteogenomic subtyping of chronic lymphocytic leukemia identifies subgroups with contrasting clinical outcome and distinct ex-vivo drug response profile

ORGANISM(S): Homo sapiens (Human)

2022-10-17 | PXD028936 | Pride

Lymphoblast B-cell Chronic lymphoblastic leukemia Proteogenomics Human Lc-ms Leukemia Cancer Clinical samples. Hirief Proteomics

Multiomic profiling of iron-deficient infant monkeys reveals alterations in neurologically important biochemicals in serum and cerebrospinal fluid before the onset of anemia

The effects of iron deficiency (ID) during infancy extend beyond the hematologic compartment and include short- and long-term adverse effects on many tissues including the brain. However, sensitive biomarkers of iron-dependent brain health are lacking in humans. To determine whether serum and cer...

2022-07-12 | MTBLS3388 | MetaboLights

Proteomic Analysis of Lyme Disease: Global Protein Comparison of Three Strains of Borrelia Burgdorferi

We report the proteomic analysis of the archetype B. burgdorferi B31 strain and two other strains (ND40, and JD-1) having different Borrelia pathotypes using strong cation exchange fractionation of proteolytic peptides followed by high-resolution, reversed phase capillary liquid chromatography coupl...

ORGANISM(S): Borreliella Burgdorferi (ncbitaxon:139)

2020-05-29 | MSV000085503 | MassIVE

Targeting the SREBP-dependent lipidomic reprogramming by virus infection for broad-spectrum therapeutic intervention

Viruses are obligate intracellular parasites that exploit the host metabolic machineries to meet their extraordinary biosynthetic demands. Integrative transcriptomic and lipidomic profiling confirmed that Middle East respiratory syndrome coronavirus (MERS-CoV) infection reprograms the host lipid met...

2018-11-26 | MTBLS762 | MetaboLights

Species-specific and cross-reactive IgG1 antibody binding to viral capsid protein 1 (VP1) antigens of human rhinovirus species A, B and C.

Not available

S-EPMC3737412 | biostudies-literature

Subtle differences in the pathogenicity of SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in rhesus macaques.

Not available

S-EPMC8535829 | biostudies-literature

UK B.1.1.7 variant exhibits increased respiratory replication and shedding in nonhuman primates.

Not available

S-EPMC8219096 | biostudies-literature

Subtle differences in the pathogenicity of SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in rhesus macaques.

Not available